Homocysteine is needed by our body for proper functioning, but its excess can cause a small natural disaster in the body – especially in the coronary system. This is where betaine comes in, ensuring that homocysteine levels never exceed the “critical dose”. What else is worth knowing about this process?
Contents
What is homocysteine and why do its levels matter?
Homocysteine is a sulfur-containing intermediate amino acid, naturally produced in the body during the metabolism of methionine – supplied with the diet along with protein. It is not a compound needed for tissue building or protein synthesis, but rather acts as a transient metabolite that should be quickly converted into other compounds: methionine (in the remethylation process – in the body, methionine, among other things, protects hair from oxidative stress), or cysteine (in the transsulfuration pathway; cysteine has antioxidant properties and is essential for the synthesis of another important substance – gluconate).
The proper course of these processes depends on the efficient action of enzymes and the appropriate availability of metabolic cofactors, such as B vitamins (including B6, B12, and folic acid), as well as compounds involved in methylation reactions. Under physiological conditions, homocysteine remains at a low level and does not show toxic effects – the problem arises only when the mechanisms of its transformations are disturbed.
Too high homocysteine levels and health
Elevated homocysteine levels (hyperhomocysteinemia) are currently recognized as an independent risk factor for the development of cardiovascular diseases. Research indicates that an excess of homocysteine can contribute to damage to the vascular endothelium, increased oxidative stress, impaired blood vessel function, and inflammatory processes, which can contribute to the development of atherosclerosis, hypertension, and thrombosis. Potential causes of its elevated concentration include deficiencies of B vitamins, liver dysfunction, kidney diseases, genetic factors (e.g., polymorphisms of methylation metabolism enzymes), chronic stress, smoking, and a high-protein (keto) diet coupled with a deficiency of components supporting metabolic pathways. For this reason, homocysteine level control is treated not only as a biochemical indicator but also as an element of a broader assessment of metabolic and cardiovascular risk.
Mechanism of betaine’s action in lowering homocysteine
A key process regulating homocysteine levels in the body is methylation, i.e., the transfer of methyl groups (-CH₃) between molecules. This is one of the basic biochemical mechanisms, essential, among others, for DNA synthesis, gene expression regulation, neurotransmitter production, and proper functioning of the cardiovascular system. In the context of homocysteine, methylation enables its conversion back into methionine – the amino acid from which it originally originated. Betaine (trimethylglycine) plays a special role in this process because it is a direct donor of methyl groups in the so-called alternative pathway of homocysteine remethylation, occurring mainly in the liver and kidneys. Thanks to this, it can support the reduction of homocysteine concentration independently of the pathway in which homocysteine is broken down with the participation of folic acid and vitamin B12.
At the same time, it is worth emphasizing that homocysteine metabolism relies on the close cooperation of several nutrients. Folates and vitamin B12 participate in the so-called one-carbon cycle, enabling the transfer of methyl groups in enzymatic reactions, while betaine complements them by providing an additional source of methylation in situations of increased demand or limited availability of B vitamins. Disruption of the balance between these components – e.g., due to nutritional deficiencies, reduced enzyme activity, or increased metabolic load – can lead to ineffective “utilization” of homocysteine and its accumulation in the blood. For this reason, betaine is perceived as an important element supporting the physiological mechanisms regulating homocysteine levels, and not as a substance acting in isolation from the entire metabolic context, a thesis also adopted by researchers when developing clinical trials.
Why does betaine supplementation support the heart?
Clinical studies indicate that betaine supplementation indeed lowers homocysteine levels in the blood. A meta-analysis of five controlled studies showed that daily intake of betaine in doses ≥4 g for at least 6 weeks led to a statistically significant reduction in homocysteine concentration by an average of ~1.23 μmol/L in the blood compared to placebo (P = .01) 1. Other studies have confirmed that betaine can also limit the increase in homocysteine after dietary methionine load, and even more effectively than folates in short-term tests.
Such a reduction in homocysteine concentration has potential significance for heart health, as epidemiological analyses suggest that even a small reduction in homocysteine is associated with a lower risk of cardiovascular disease and stroke. Nevertheless, direct clinical evidence that betaine supplementation translates into a lower risk of cardiovascular events (e.g., heart attack or stroke) is limited – most studies concern biochemical markers, not long-term clinical outcomes2.
When to consider supplementation and medical consultation
The highest risk of elevated homocysteine levels is observed in people:
- with deficiencies of vitamins involved in methylation (especially vitamin B12 and folic acid),
- with kidney disease,
- who smoke cigarettes,
- with genetic predispositions to homocysteine metabolism disorders.
High homocysteine concentration can also accompany aging, some chronic diseases, or diets poor in key cofactors of remethylation enzymes.
In such situations, it is worth considering measuring homocysteine concentration in the blood and consulting a doctor or nutritionist. Medical assessment allows determining whether we are dealing with hyperhomocysteinemia, what are the potential causes of such a condition, and whether betaine supplementation (or other components supporting homocysteine metabolism, such as folates and vitamin B12 in the form of supplements like Best B-Complex) is indicated as an element of the therapeutic strategy. Supplementation – if considered – should be individually tailored and monitored, especially in the context of other cardiovascular risk factors.
Bibliography:
- M. P McRae, Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis, Journal of Chiropractic medicine, nr 12/2013, z. 1.
- G.R.Steenge, P.Verhoef, M.B.Katan, Betaine supplementation lowers plasma homocysteine in healthy men and women, Journal of Nutrition, nr 133/2003, z. 5